Natural compounds as safe therapeutic options for ulcerative colitis

被引:50
|
作者
Gupta, Mukta [1 ]
Mishra, Vijay [1 ]
Gulati, Monica [1 ]
Kapoor, Bhupinder [1 ]
Kaur, Amrinder [1 ]
Gupta, Reena [1 ]
Tambuwala, Murtaza M. [2 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara 144411, Punjab, India
[2] Ulster Univ, Sch Pharm & Pharmaceut Sci, Coleraine BT52 1SA, Londonderry, North Ireland
关键词
Ulcerative colitis; Herbal constituents; Anti-ulcerogenic activity; Inflammatory bowel disease; ARCTIUM-LAPPA L; DEXTRAN SULFATE SODIUM; LONICERA-JAPONICA THUNB; TNBS-INDUCED COLITIS; RHEUM-TANGUTICUM POLYSACCHARIDE; TEA CAMELLIA-SINENSIS; ACID-INDUCED COLITIS; SYLVESTRE R. BR; GREEN TEA; GYMNEMA-SYLVESTRE;
D O I
10.1007/s10787-022-00931-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology. Several conventional treatments for UC such as corticosteroids, immunosuppressive agents, tumor necrosis factor antagonist, integrin blockers, and interleukin antagonist, and salicylates are available but are associated with the various limitations and side-effects. None of the above treatments helps to achieve the ultimate goal of the therapy, i.e., maintenance of remission in the long-term. Natural remedies for the treatment of UC show comparatively less side effects as compared to conventional approaches, and affordable. The current review presents details on the role of herbal drugs in the treatment and cure of UC. Google, PubMed, Web of Science, and Scopus portals have been searched for potentially relevant literature to get the latest developments and updated information related to use of natural drugs in the treatment of UC. Natural products have been used over centuries to treat UC. Some of the essential herbal constituents exhibiting antiulcerogenic activity include gymnemic acid (Gymnema sylvestre), shagoal (Zingiber officinale), catechin (Camellia sinensis), curcumin (Curcuma longa), arctigenin (Arctium lappa), and boswellic acid (Boswellia serrata). Although many plant-derived products have been recommended for UC, further research to understand the exact molecular mechanism is still warranted to establish their usefulness clinically.
引用
收藏
页码:397 / 434
页数:38
相关论文
共 50 条
  • [21] MEDICAL AND SURGICAL OPTIONS FOR ULCERATIVE-COLITIS
    LEVINE, DS
    CURRENT OPINION IN GASTROENTEROLOGY, 1995, 11 (01) : 29 - 35
  • [22] Oral Budesonide: Treatment options in Ulcerative Colitis?
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (18) : 935 - 935
  • [23] Emerging oral drug options for ulcerative colitis
    Salvatori, Silvia
    Neri, Benedetto
    Marafini, Irene
    Brigida, Mattia
    Monteleone, Giovanni
    EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (03) : 191 - 201
  • [24] Online Education Significantly Improved Gastroenterologists' Knowledge of Treatment Options and Therapeutic Goals in Ulcerative Colitis
    Bell, E.
    Calle, M.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S534 - S535
  • [25] Towards therapeutic choices in ulcerative colitis
    Laharie, David
    LANCET, 2017, 390 (10090): : 98 - 99
  • [26] DIAGNOSTIC AND THERAPEUTIC BRIEFS - ULCERATIVE COLITIS
    HENNING, N
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1958, 83 (40) : 1792 - 1792
  • [27] Therapeutic strategy in ulcerative colitis - 2004
    Rachmilewitz, D
    INFLAMMATORY BOWEL DISEASE: TRANSLATION FROM BASIC RESEARCH TO CLINICAL PRACTICE, 2005, 140 : 270 - 274
  • [28] Nonbiological therapeutic management of ulcerative colitis
    Mezzina, Nicolo
    Davies, Sophia Elizabeth Campbell
    Ardizzone, Sandro
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (16) : 1747 - 1757
  • [29] A review of the therapeutic management of ulcerative colitis
    Aslam, Nasar
    Lo, Sheng Wei
    Sikafi, Rafid
    Barnes, Tom
    Segal, Jonathan
    Smith, Philip J.
    Limdi, Jimmy K.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [30] THERAPEUTIC PROBLEMS OF ULCERATIVE COLITIS WITH HYPERTHYROIDISM
    POWELL, JR
    SHAPRIO, HA
    CARBONE, JV
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1968, 50 (02): : 116 - &